[1] Duan M, Hao J, Cui S, et al. Diverse modes of clonal evolution in HBV-related hepatocellular carcinoma revealed by single-cell genome sequencing. Cell Res, 2018,28:359-373. [2] 宁晓艳,林海燕,黄鑫, 等.乙型肝炎病毒感染相关性肝癌患者的临床特征分析.肝脏,2017,22:556-557. [3] 中华人民共和国卫生部.原发性肝癌诊疗规范(2011年版). 临床肿瘤学杂志, 2011, 16:929-946. [4] 中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南(2015更新版). 中华传染病杂志,2015,33:641-662. [5] Chai Y, Xiaoyu L, Haiyan W. Correlation between expression levels of PTEN and p53 genes and the clinical features of HBsAg-positive liver cancer. J BUON,2017,22:942-946. [6] Jiang J, Hu H, Liu R, et al. Nomogram for individualized prediction of recurrence after postoperative adjuvant TACE for hepatitis B virus-related hepatocellular carcinoma. Medicine (Baltimore),2017,96: e7390. [7] Xu W, Yu J, Wong VW. Mechanism and prediction of HCC development in HBV infection. Best Pract Res Clin Gastroenterol,2017,31:291-298. [8] Hu Z, Luo D, Wang D, et al. IL-17 activates the IL-6/STAT3 signal pathway in the proliferation of hepatitis B virus-related hepatocellular carcinoma. Cell Physiol Biochem, 2017,43:2379-2390. [9] 沙敏,王变,肖丽,等.miR-212/132在原发性肝癌患者血清中的表达及其对高尔基体糖蛋白73的靶向调控.中华肝脏病杂志,2017,25:920-926. [10] Zhu HT, Dong QZ, Sheng YY, et al. MicroRNA-29a-5p is a novel predictor for early recurrence of hepatitis B virus-related hepatocellular carcinoma after surgical resection.PLoS One,2012,7: e52393. |